Form 4: Guardant Health Director Myrtle S. Potter Reports Stock Transactions
SEC Form 4 Filing
Director Myrtle S. Potter reports the vesting and conversion of restricted stock units into common stock of Guardant Health, Inc.
Summary
- On July 15, 2024, Myrtle S. Potter, a director of Guardant Health, Inc., reported transactions involving restricted stock units.
- 69 restricted stock units vested and were converted into 69 shares of common stock.
- The price for both the restricted stock units and the acquired common stock was $0.
- Following the transaction, Potter directly owns 13,380 shares of Guardant Health common stock and 1,026 derivative securities.
- The restricted stock units vest in installments, beginning October 15, 2022, and continuing monthly over three years.
Sentiment
Score: 5
Explanation: This is a neutral regulatory filing detailing stock transactions by a company insider. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It does not provide any insight into the company's performance or strategy.
Key Dates
| Date | Description |
|---|---|
| October 15, 2022 | Initial vesting date for 25% of the restricted stock units. |
| July 15, 2024 | Date of transaction: conversion of restricted stock units to common stock. |
| July 16, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.